EBI Life Sciences Overview

  • Founded
  • 2011
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

EBI Life Sciences General Information


Operator of a medical research company intended to develop and produce veterinary pharmaceutical products. The company's services are focused on developing bicifadine, a serotonin-norepinephrine reuptake inhibitor, for the treatment of chronic and acute pain in companion animals, enabling healthcare professionals to help animals recover in a swift manner from body pain.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 43 Thorndike Street
  • Suite S1-3
  • Cambridge, MA 02141
  • United States
+1 (617) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

EBI Life Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 10-Nov-2017 000.00 Completed Out of Business
2. Secondary Transaction - Private 000.00 Completed Startup
1. Early Stage VC (Series A) 30-May-2012 $27.3K $27.3K Completed Startup
To view EBI Life Sciences’s complete valuation and funding history, request access »